Breast Cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group: intervention group: exercise group
They receive an exercise program including 12-week supervised exercises developed by a sports physiologist, 3 days a week for 50-60 minutes. This program will include aerobic exercises, resistance exe
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Female
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients aged 15 to 75 who have been diagnosed with grade I to III breast cancer based on pathology; Have completed intensive breast cancer treatment (including surgery, chemotherapy, or radiation therapy); Have the recommendation and permission to participate in the exercises program from the oncologist; Three weeks after chemotherapy or radiation therapy; Less than 6 months have passed since chemotherapy or radiation therapy; Patients should be able to do aerobic and resistance exercises.
Exclusion criteria
Exclusion criteria: Having an acute illness or a serious psychiatric illness; Patients with recurrence or metastasis; Suffering from other diseases or other continuous treatments such as asthma or osteoporosis and heart disease and blood pressure; Anemia with a decrease in red blood cells; Ataxia (imbalance in walking); Patients have not been approved by the oncologist for exercise.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The coping self-efficacy score in the questionnaire has 3 dimensions (stopping emotions and unpleasant thoughts), (problem-oriented strategy), and (receiving support from family and friends). The total scores for each item of that dimension are calculated together. Respondents must answer at least 80% of the scale items. Timepoint: Measuring coping self-efficacy at the beginning of the study (before the start of the intervention) and at the end of the intervention (12 weeks after the start of the study). Method of measurement: Chesney et al. Coping Self-Efficacy Questionnaire (CSES).;The quality of life score of breast cancer patients in the QLQ-Br23 questionnaire includes 23 items that are divided into two dimensions. The first dimension includes four functional scales, (sexual function, sexual pleasure, and future perspective); While the second dimension includes four symptom scales (systemic treatment side effects, breast symptoms, arm symptoms, hair loss discomfort). Each item is scored from 1 to 4 points. Scores are converted to a 0-100 score after linear transformation. The highest scores correspond to better performance (except for sexual performance and sexual pleasure). On the other hand, higher scores on the symptom scale dimension are associated with higher persistence of signs and symptoms. Timepoint: Measuring quality of life at the beginning of the study (before the start of the intervention) and at the end of the intervention (12 weeks after the start of the study). Method of measurement: Breast Cancer Quality of Life Questionnaire (EORTC-QLQ-BR23). | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce anxiety. Timepoint: End of the intervention (after 12 weeks from the start of the intervention). Method of measurement: Hospital Anxiety and Depression Scale (HADS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaridokht Yazdani
Islamic Azad University
Outcome results
None listed